Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00418054
What this trial is testing

Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C
Romark Laboratories L.C. 40
Post-approval studies (Phase 4)UnknownNCT02802280
What this trial is testing

Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents.

Who this might be right for
Hepatitis CCardiovascular Diseases
Instituto de Investigación Marqués de Valdecilla 80
Not applicableStudy completedNCT00723242
What this trial is testing

The Role of Dendritic Cells in Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C Infection
University College, London
Testing effectiveness (Phase 2)Study completedNCT01226446
What this trial is testing

Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 32
Not applicableStudy completedNCT00076427
What this trial is testing

Leukapheresis for Research on HCV-Coinfected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 327
Large-scale testing (Phase 3)Study completedNCT00262379
What this trial is testing

Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University Hospital, Angers 229
Post-approval studies (Phase 4)Study completedNCT02759861
What this trial is testing

Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics

Who this might be right for
Genotype 1 Hepatitis C Virus
University of Nebraska 16
Not applicableEnded earlyNCT00723879
What this trial is testing

Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)

Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 115
Not applicableEnded earlyNCT02056054
What this trial is testing

De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation

Who this might be right for
De Novo Autoimmune Hepatitis
Yale University 157
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Large-scale testing (Phase 3)Study completedNCT02203149
What this trial is testing

Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 399
Not applicableLooking for participantsNCT05181826
What this trial is testing

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Who this might be right for
CancerLiver CirrhosisChronic Hepatitis+4 more
Helio Genomics 1,200
Large-scale testing (Phase 3)Study completedNCT01889433
What this trial is testing

An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C

Who this might be right for
HepatitisHepatitis C
Biocad 170
Testing effectiveness (Phase 2)Study completedNCT00663208
What this trial is testing

A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 167
Testing effectiveness (Phase 2)Study completedNCT00919633
What this trial is testing

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C

Who this might be right for
Hepatitis C
Medtronic Corporate Technologies and New Ventures 116
Early research (Phase 1)Study completedNCT00801255
What this trial is testing

Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Not applicableUnknownNCT01572233
What this trial is testing

Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
National Taiwan University Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00704184
What this trial is testing

Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 95
Post-approval studies (Phase 4)Study completedNCT03710252
What this trial is testing

Investigate HCV Response Rates in Real World Patients: HEARTLAND Study

Who this might be right for
Chronic Hepatitis C
American Research Corporation 100
Early research (Phase 1)Study completedNCT01431898
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Gilead Sciences 82
Next Page